Abstract

Baclofen 10 mg/mL in SyrSpend SF pH4

Author(s): Allen Loyd V Jr

Issue: May/Jun 2020 - Volume 24, Number 3

Page(s): 224

Download in electronic PDF format for $75
  • Baclofen 10 mg/mL in SyrSpend SF pH4 Page 1

Abstract

A formulation for preparing Baclofen 10 mg/mL in SyrSpend SF pH4. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • baclofen
  • gamma-butyric acid derivative
  • GABA
  • skeletal muscle relaxant
  • spasticity
  • choreiform movements
  • Huntington chorea
  • rigidity
  • parkinsonism
  • Parkinson disease
  • muscle spasms
  • cerebral palsy
  • rheumatic disorders
  • spinal cord injury

Related Categories

  • FORMULATIONS
  • MUSCULOSKELETAL DISORDERS
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2020
Pg. 224
Baclofen 10 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 2024
Pg. 136
Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base
Author(s): Allen Loyd V Jr
May/Jun 2017
Pg. 234
Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Jul/Aug 2017
Pg. 339-346
Stability of Acetazolamide, Baclofen, Dipyridamole, Mebeverine Hydrochloride, Propylthiouracil, Quinidine Sulfate, and Topiramate Oral Suspensions in SyrSpend SF PH4
Author(s): de Oliveira Ferreira Anderson, Polonini Hudson, Loures da Silva Sharlene, Buzinari Aglio Natália Cristina, Abreu Jordana, Fernandes Brandão Marcos Antônio
Mar/Apr 2020
Pg. 156-162
Physicochemical Stability of Ternary Mixtures of Sufentanil, Baclofen, and Ropivacaine in Polypropylene Syringes for Intrathecal Analgesia
Author(s): Sorrieul Jérémy, Robert Julien, Chapel Fanny, Gossye Thomas, Devys Catherine
Nov/Dec 2010
Pg. 512
Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel
Author(s): Allen Loyd V Jr
Nov/Dec 2010
Pg. 513
Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel
Author(s): Allen Loyd V Jr
Nov/Dec 2010
Pg. 514
Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel
Author(s): Allen Loyd V Jr
Jul/Aug 2020
Pg. 313
Cyclobenzaprine 5-mg/g and Guaifenesin 10-mg/g Transdermal Cream
Author(s): Allen Loyd V Jr
Nov/Dec 2018
Pg. 516-526
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4
Author(s): Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
Nov/Dec 2019
Pg. 495
Zonisamide 10 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Nov/Dec 2009
Pg. 569-571
The Release and Transdermal Penetration of Baclofen Formulated in a Poloxamer Lecithin Organogel
Author(s): Arnold John J, Asbill Scott
May/Jun 2012
Pg. 245
Orphenadrine Citrate 30-mg/mL Injection
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 412
Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2024
Pg. 135
Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm
Author(s): Allen Loyd V Jr
May/Jun 2016
Pg. 231
Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm
Author(s): Allen Loyd V Jr
Jan/Feb 2002
Pg. 44
Fentanyl 10-mcg/mL, Bupivacaine 5-mg/mL, and Baclofen 25-mcg/mL Injection
Author(s): Allen Loyd V Jr
Jul/Aug 1999
Pg. 309-310
Acidifying Agents, Featured Excipient:
Author(s): Allen Loyd V Jr